Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03390998 · ClinicalTrials.gov registry record

Angiographic and Psychosocial Evaluation of Peripartum vs. Non: SCAD

A clinical trial of Spontaneous Coronary Artery Dissection, sponsored by Katharine Sears Edwards.

Completed
Registry status
241
Enrollment target
1
Study location

NCT03390998 is a study of Spontaneous Coronary Artery Dissection that has completed, run by Katharine Sears Edwards. The registered enrollment target is 241 participants, below the 840-participant average among 5 other Spontaneous Coronary Artery Dissection trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03390998, a study of Spontaneous Coronary Artery Dissection, has completed, sponsored by Katharine Sears Edwards.

COMPLETED
Registry status
241 participants
Enrollment target
1
Study location

Study Summary

This multi-site international clinical research project is a collaboration between investigators from multiple institutions in the USA, Canada, and Europe. Approximately 7 to 11 sites will participate and provide data for analysis. Clinical operations (for data collection and analysis) across sites will be managed by Stanford. The study purpose is to determine differences in clinical and imaging presentation, in-hospital management and prognosis in peripartum and non-peripartum SCAD patients.

Study Locations (1)

California

  • Stanford University Medical Center - Palo Alto

Trial Details

FieldValue
Enrollment Target 241 participants
Start Date 2017-11-28
Est. Completion 2019-05-31

Sponsor

Katharine Sears Edwards

1 total trials

What the Registry Record Tells You About NCT03390998

The ClinicalTrials.gov registry entry for NCT03390998 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 241 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 840-participant average among 5 other Spontaneous Coronary Artery Dissection trials with a reported enrollment target (71% lower). The listed sponsor is Katharine Sears Edwards, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Spontaneous Coronary Artery Dissection appearing as the primary indexed condition, and to 0 interventions.

NCT03390998 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03390998 about?

NCT03390998 is a clinical study titled "Angiographic and Psychosocial Evaluation of Peripartum vs. Non: SCAD". This multi-site international clinical research project is a collaboration between investigators from multiple institutions in the USA, Canada, and Europe. Approximately 7 to 11 sites will participate and provide data for analysis. Clinical operations (for data collection and analysis) across sites ...

What is the current status of trial NCT03390998?

This trial is currently completed. The enrollment target is 241 participants. The study started on 2017-11-28. Estimated completion is 2019-05-31.

What conditions does trial NCT03390998 study?

This clinical trial studies the following conditions: Spontaneous Coronary Artery Dissection.

Who is sponsoring clinical trial NCT03390998?

This trial is sponsored by Katharine Sears Edwards, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03390998 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spontaneous Coronary Artery Dissection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.